Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses.

Pollara J, Hart L, Brewer F, Pickeral J, Packard BZ, Hoxie JA, Komoriya A, Ochsenbauer C, Kappes JC, Roederer M, Huang Y, Weinhold KJ, Tomaras GD, Haynes BF, Montefiori DC, Ferrari G.

Cytometry A. 2011 Aug;79(8):603-12. doi: 10.1002/cyto.a.21084. Epub 2011 Jul 6.

2.

Multiparametric analysis of apoptosis by flow cytometry.

Telford WG, Komoriya A, Packard BZ, Bagwell CB.

Methods Mol Biol. 2011;699:203-27. doi: 10.1007/978-1-61737-950-5_10.

PMID:
21116985
3.

A method in enzymology for measuring hydrolytic activities in live cell environments.

Packard BZ, Komoriya A.

Methods Enzymol. 2008;450:1-19. doi: 10.1016/S0076-6879(08)03401-0.

PMID:
19152853
4.

Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control.

Migueles SA, Osborne CM, Royce C, Compton AA, Joshi RP, Weeks KA, Rood JE, Berkley AM, Sacha JB, Cogliano-Shutta NA, Lloyd M, Roby G, Kwan R, McLaughlin M, Stallings S, Rehm C, O'Shea MA, Mican J, Packard BZ, Komoriya A, Palmer S, Wiegand AP, Maldarelli F, Coffin JM, Mellors JW, Hallahan CW, Follman DA, Connors M.

Immunity. 2008 Dec 19;29(6):1009-21. doi: 10.1016/j.immuni.2008.10.010. Epub 2008 Dec 8.

5.

Direct visualization of protease activity on cells migrating in three-dimensions.

Packard BZ, Artym VV, Komoriya A, Yamada KM.

Matrix Biol. 2009 Jan;28(1):3-10. doi: 10.1016/j.matbio.2008.10.001. Epub 2008 Oct 29.

6.
7.

Granzyme B activity in target cells detects attack by cytotoxic lymphocytes.

Packard BZ, Telford WG, Komoriya A, Henkart PA.

J Immunol. 2007 Sep 15;179(6):3812-20.

8.

Characterization of fluorescence quenching in bifluorophoric protease substrates.

Packard BZ, Toptygin DD, Komoriya A, Brand L.

Biophys Chem. 1997 Sep 1;67(1-3):167-76.

PMID:
17029895
9.

DPSS yellow-green 561-nm lasers for improved fluorochrome detection by flow cytometry.

Telford W, Murga M, Hawley T, Hawley R, Packard B, Komoriya A, Haas F, Hubert C.

Cytometry A. 2005 Nov;68(1):36-44.

10.

Multiparametric analysis of apoptosis by flow and image cytometry.

Telford WG, Komoriya A, Packard BZ.

Methods Mol Biol. 2004;263:141-60.

PMID:
14976365
11.

Assessment of lymphocyte-mediated cytotoxicity using flow cytometry.

Liu L, Packard BZ, Brown MJ, Komoriya A, Feinberg MB.

Methods Mol Biol. 2004;263:125-40.

PMID:
14976364
12.

Caspase activity is not sufficient to execute cell death.

Lukovic D, Komoriya A, Packard BZ, Ucker DS.

Exp Cell Res. 2003 Oct 1;289(2):384-95.

PMID:
14499640
13.

The effector phase of physiological cell death relies exclusively on the posttranslational activation of resident components.

Chang SH, Cvetanovic M, Harvey KJ, Komoriya A, Packard BZ, Ucker DS.

Exp Cell Res. 2002 Jul 1;277(1):15-30.

PMID:
12061814
14.

Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates.

Liu L, Chahroudi A, Silvestri G, Wernett ME, Kaiser WJ, Safrit JT, Komoriya A, Altman JD, Packard BZ, Feinberg MB.

Nat Med. 2002 Feb;8(2):185-9.

PMID:
11821904
15.

Detection of localized caspase activity in early apoptotic cells by laser scanning cytometry.

Telford WG, Komoriya A, Packard BZ.

Cytometry. 2002 Feb 1;47(2):81-8.

16.

Caspase 8 activity in membrane blebs after anti-Fas ligation.

Packard BZ, Komoriya A, Brotz TM, Henkart PA.

J Immunol. 2001 Nov 1;167(9):5061-6.

17.

Assessment of caspase activities in intact apoptotic thymocytes using cell-permeable fluorogenic caspase substrates.

Komoriya A, Packard BZ, Brown MJ, Wu ML, Henkart PA.

J Exp Med. 2000 Jun 5;191(11):1819-28.

18.

Tumor cell recognition by lymphocytes: is the MHC always essential?

Packard BZ, Komoriya A.

Crit Rev Immunol. 1998;18(1-2):139-44. Review.

PMID:
9419456
19.

Design of profluorescent protease substrates guided by exciton theory.

Packard BZ, Toptygin DD, Komoriya A, Brand L.

Methods Enzymol. 1997;278:15-23. Review. No abstract available.

PMID:
9170307
20.

Profluorescent protease substrates: intramolecular dimers described by the exciton model.

Packard BZ, Toptygin DD, Komoriya A, Brand L.

Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11640-5.

21.

Mitogenic stimulation of human lymphocytes mediated by a cell surface elastase.

Packard BZ, Mostowski HS, Komoriya A.

Biochim Biophys Acta. 1995 Oct 19;1269(1):51-6.

22.

A serpin from human tumor cells with direct lymphoid immunomodulatory activity: mitogenic stimulation of human tumor-infiltrating lymphocytes.

Packard BZ, Lee SS, Remold-O'Donnell E, Komoriya A.

Biochim Biophys Acta. 1995 Oct 19;1269(1):41-50.

23.

A 36-kilodalton tumor-derived factor with myeloid immunomodulatory activity.

Packard BZ, Komoriya A.

J Biol Chem. 1993 Mar 25;268(9):6356-63.

24.

A structure function study of C-terminal extensions of bombesin.

Mervic M, Moody TW, Komoriya A.

Peptides. 1991 Sep-Oct;12(5):1149-51.

PMID:
1666185
27.

VLA-4 mediates CD3-dependent CD4+ T cell activation via the CS1 alternatively spliced domain of fibronectin.

Nojima Y, Humphries MJ, Mould AP, Komoriya A, Yamada KM, Schlossman SF, Morimoto C.

J Exp Med. 1990 Oct 1;172(4):1185-92.

28.

Insulin binding to its receptor induces a conformational change in the receptor C-terminus.

Baron V, Gautier N, Komoriya A, Hainaut P, Scimeca JC, Mervic M, Lavielle S, Dolais-Kitabgi J, Van Obberghen E.

Biochemistry. 1990 May 15;29(19):4634-41.

PMID:
2196938
29.
30.

Phorbol ester and interferon-gamma modulation of epidermal growth factor receptors on human amniotic (WISH) cells.

Karasaki Y, Jaken S, Komoriya A, Zoon KC.

J Biol Chem. 1989 Apr 15;264(11):6158-63.

31.

Kinetic parameters of the protein tyrosine kinase activity of EGF-receptor mutants with individually altered autophosphorylation sites.

Honegger A, Dull TJ, Szapary D, Komoriya A, Kris R, Ullrich A, Schlessinger J.

EMBO J. 1988 Oct;7(10):3053-60.

32.
34.

Mapping a region associated with Na channel inactivation using antibodies to a synthetic peptide corresponding to a part of the channel.

Meiri H, Spira G, Sammar M, Namir M, Schwartz A, Komoriya A, Kosower EM, Palti Y.

Proc Natl Acad Sci U S A. 1987 Jul;84(14):5058-62.

35.
36.

Inhibition of endothelial cell proliferation by gamma-interferon.

Friesel R, Komoriya A, Maciag T.

J Cell Biol. 1987 Mar;104(3):689-96.

37.

Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion.

Humphries MJ, Akiyama SK, Komoriya A, Olden K, Yamada KM.

J Cell Biol. 1986 Dec;103(6 Pt 2):2637-47.

38.

Site-directed labeling of a monoclonal antibody: targeting to a disulfide bond.

Packard B, Edidin M, Komoriya A.

Biochemistry. 1986 Jun 17;25(12):3548-52.

PMID:
3718943
39.

Crystallographic structure of an active, sequence-engineered ribonuclease.

Taylor HC, Komoriya A, Chaiken IM.

Proc Natl Acad Sci U S A. 1985 Oct;82(19):6423-6.

40.

Biologically active synthetic fragments of epidermal growth factor: localization of a major receptor-binding region.

Komoriya A, Hortsch M, Meyers C, Smith M, Kanety H, Schlessinger J.

Proc Natl Acad Sci U S A. 1984 Mar;81(5):1351-5.

41.

Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.

Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB.

J Biol Chem. 1983 Jun 10;258(11):7155-60.

42.

Minimum information content and formation of interacting ribonuclease fragment complexes.

Kanmera T, Homandberg GA, Komoriya A, Chaiken IM.

Int J Pept Protein Res. 1983 Jan;21(1):74-83.

PMID:
6826284
43.

Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells.

Anzano MA, Roberts AB, Meyers CA, Komoriya A, Lamb LC, Smith JM, Sporn MB.

Cancer Res. 1982 Nov;42(11):4776-8.

44.

Use of enzymes in peptide synthesis.

Chaiken IM, Komoriya A, Ohno M, Widmer F.

Appl Biochem Biotechnol. 1982 Sep;7(5):385-99. doi: 10.1007/BF02798320.

PMID:
24234364
45.

Enzymatic condensation of nonassociated peptide fragments using a molecular trap.

Homandberg GA, Komoriya A, Chaiken IM.

Biochemistry. 1982 Jul 6;21(14):3385-9.

PMID:
7052121
46.

Sequence modeling using semisynthetic ribonuclease S.

Komoriya A, Chaiken IM.

J Biol Chem. 1982 Mar 10;257(5):2599-604.

47.

"Active" conformation of an inactive semi-synthetic ribonuclease-S.

Taylor HC, Richardson DC, Richardson JS, Wlodawer A, Komoriya A, Chaikes IM.

J Mol Biol. 1981 Jun 25;149(2):313-7. No abstract available.

PMID:
7310884
48.

Enzyme-catalyzed formation of semisynthetic staphylococcal nuclease using a new synthetic fragment, [48-glycine]synthetic-(6-49).

Komoriya A, Homandberg GA, Chaiken IM.

Int J Pept Protein Res. 1980 Nov;16(5):433-9.

PMID:
7216618
49.

Local interactions as a structure determinant for protein molecules: III.

Krigbaum WR, Komoriya A.

Biochim Biophys Acta. 1979 Jan 25;576(1):229-46.

PMID:
760807
50.

Local interactions as a structure determinant for protein molecules: II.

Krigbaum WR, Komoriya A.

Biochim Biophys Acta. 1979 Jan 25;576(1):204-48.

PMID:
760806

Supplemental Content

Loading ...
Support Center